Kohli et al. performed the iTRAQ-based proteomic analysis coupled with ELISA validation and found that urinary EPCR and dermcidin may emerge as novel biomarkers for screening severe OSA patients (Kohli et al., 2019). Here, PROCR is linked to obstructive sleep apnea syndrome.